during the disease, whereas other locations manage capabilities currently existing in several levels of B-cell differentiation. Investigation with the CLL microenvironment has delivered clues to be familiar with the survival of tumor cells and resistance to therapy. All of this knowledge has made available new perspectives that are now being exploi